JPH0138797B2 - - Google Patents
Info
- Publication number
- JPH0138797B2 JPH0138797B2 JP55034797A JP3479780A JPH0138797B2 JP H0138797 B2 JPH0138797 B2 JP H0138797B2 JP 55034797 A JP55034797 A JP 55034797A JP 3479780 A JP3479780 A JP 3479780A JP H0138797 B2 JPH0138797 B2 JP H0138797B2
- Authority
- JP
- Japan
- Prior art keywords
- solution
- bis
- keto
- dihydroxypropyl
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- QZUPTXGVPYNUIT-UHFFFAOYSA-N isophthalamide Chemical compound NC(=O)C1=CC=CC(C(N)=O)=C1 QZUPTXGVPYNUIT-UHFFFAOYSA-N 0.000 claims description 24
- 239000000203 mixture Substances 0.000 claims description 15
- 239000002872 contrast media Substances 0.000 claims description 11
- 238000012800 visualization Methods 0.000 claims description 7
- -1 2,3-dihydroxypropyl Chemical group 0.000 claims description 4
- 230000005855 radiation Effects 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 93
- 239000000243 solution Substances 0.000 description 60
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 39
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 37
- 239000000047 product Substances 0.000 description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 26
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 25
- 150000001875 compounds Chemical class 0.000 description 23
- 238000004809 thin layer chromatography Methods 0.000 description 17
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 16
- 238000000034 method Methods 0.000 description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 13
- 239000000463 material Substances 0.000 description 13
- 239000007787 solid Substances 0.000 description 13
- 238000004458 analytical method Methods 0.000 description 12
- 235000019439 ethyl acetate Nutrition 0.000 description 10
- 238000003756 stirring Methods 0.000 description 9
- 239000007864 aqueous solution Substances 0.000 description 8
- 230000002285 radioactive effect Effects 0.000 description 8
- 239000011780 sodium chloride Substances 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000011541 reaction mixture Substances 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 238000005481 NMR spectroscopy Methods 0.000 description 6
- MHABMANUFPZXEB-UHFFFAOYSA-N O-demethyl-aloesaponarin I Natural products O=C1C2=CC=CC(O)=C2C(=O)C2=C1C=C(O)C(C(O)=O)=C2C MHABMANUFPZXEB-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 239000003610 charcoal Substances 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 4
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 230000001154 acute effect Effects 0.000 description 4
- 150000001408 amides Chemical class 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 3
- PUMRUSBKNSBTAL-UHFFFAOYSA-N 3,4-dihydro-2h-chromene-2-carbaldehyde Chemical compound C1=CC=C2OC(C=O)CCC2=C1 PUMRUSBKNSBTAL-UHFFFAOYSA-N 0.000 description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000002583 angiography Methods 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 210000003169 central nervous system Anatomy 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- KQIGMPWTAHJUMN-UHFFFAOYSA-N 3-aminopropane-1,2-diol Chemical compound NCC(O)CO KQIGMPWTAHJUMN-UHFFFAOYSA-N 0.000 description 2
- KAEGSAWWVYMWIQ-UHFFFAOYSA-N 5-amino-1-n,3-n-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide Chemical compound NC1=C(I)C(C(=O)NCC(O)CO)=C(I)C(C(=O)NCC(O)CO)=C1I KAEGSAWWVYMWIQ-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010029350 Neurotoxicity Diseases 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 206010044221 Toxic encephalopathy Diseases 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- SHUOZUDQONPJGS-UHFFFAOYSA-N [2-acetyloxy-3-[[3-amino-5-(2,3-diacetyloxypropylcarbamoyl)-2,4,6-triiodobenzoyl]amino]propyl] acetate Chemical compound CC(=O)OCC(OC(C)=O)CNC(=O)C1=C(I)C(N)=C(I)C(C(=O)NCC(COC(C)=O)OC(C)=O)=C1I SHUOZUDQONPJGS-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 238000002586 coronary angiography Methods 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000000921 elemental analysis Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- 231100000228 neurotoxicity Toxicity 0.000 description 2
- 230000007135 neurotoxicity Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000008227 sterile water for injection Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- LJEBHEAPZMNBSI-UHFFFAOYSA-N 1-n,3-n-bis(2,3-dihydroxypropyl)-5-nitrobenzene-1,3-dicarboxamide Chemical compound OCC(O)CNC(=O)C1=CC(C(=O)NCC(O)CO)=CC([N+]([O-])=O)=C1 LJEBHEAPZMNBSI-UHFFFAOYSA-N 0.000 description 1
- PDXOPTFTOFXXSU-UHFFFAOYSA-N 1-sulfanylpentan-1-ol Chemical compound CCCCC(O)S PDXOPTFTOFXXSU-UHFFFAOYSA-N 0.000 description 1
- CIUUPJHGWDRPKJ-UHFFFAOYSA-N 2,4,5-triiodobenzene-1,3-dicarboxamide Chemical compound NC(=O)C1=CC(I)=C(I)C(C(N)=O)=C1I CIUUPJHGWDRPKJ-UHFFFAOYSA-N 0.000 description 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- VBUYCZFBVCCYFD-NUNKFHFFSA-N 2-dehydro-L-idonic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)C(=O)C(O)=O VBUYCZFBVCCYFD-NUNKFHFFSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-OUBTZVSYSA-N Carbon-13 Chemical compound [13C] OKTJSMMVPCPJKN-OUBTZVSYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- VBUYCZFBVCCYFD-UHFFFAOYSA-N D-arabino-2-Hexulosonic acid Natural products OCC(O)C(O)C(O)C(=O)C(O)=O VBUYCZFBVCCYFD-UHFFFAOYSA-N 0.000 description 1
- NVTRPRFAWJGJAJ-UHFFFAOYSA-L EDTA monocalcium salt Chemical compound [Ca+2].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O NVTRPRFAWJGJAJ-UHFFFAOYSA-L 0.000 description 1
- 102000020897 Formins Human genes 0.000 description 1
- 108091022623 Formins Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 238000003109 Karl Fischer titration Methods 0.000 description 1
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- URLKBWYHVLBVBO-UHFFFAOYSA-N Para-Xylene Chemical compound CC1=CC=C(C)C=C1 URLKBWYHVLBVBO-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- MJOQJPYNENPSSS-XQHKEYJVSA-N [(3r,4s,5r,6s)-4,5,6-triacetyloxyoxan-3-yl] acetate Chemical compound CC(=O)O[C@@H]1CO[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O MJOQJPYNENPSSS-XQHKEYJVSA-N 0.000 description 1
- 238000002584 aortography Methods 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000005013 brain tissue Anatomy 0.000 description 1
- 230000007052 brain toxicity Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 231100000976 cerebrotoxicity Toxicity 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 239000003179 convulsant agent Substances 0.000 description 1
- 230000002920 convulsive effect Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000006192 iodination reaction Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 210000003140 lateral ventricle Anatomy 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 238000009608 myelography Methods 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000010287 polarization Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 238000002390 rotary evaporation Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- UQDJGEHQDNVPGU-UHFFFAOYSA-N serine phosphoethanolamine Chemical compound [NH3+]CCOP([O-])(=O)OCC([NH3+])C([O-])=O UQDJGEHQDNVPGU-UHFFFAOYSA-N 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000013223 sprague-dawley female rat Methods 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 238000007487 urography Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/023,509 US4256729A (en) | 1979-03-23 | 1979-03-23 | N,N'-Bis-(2,3-dihydroxypropyl)-2,4,6-triiodo-5-(2-keto-L-gulonamido)isophthalamide and radiological compositions containing same |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1008741A Division JPH02146A (ja) | 1979-03-23 | 1989-01-19 | ５‐アミノ‐ｎ，ｎ’―ビス（２，３‐ジ置換プロピル）‐２，４，６‐トリヨードイソフタルアミド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS55129298A JPS55129298A (en) | 1980-10-06 |
| JPH0138797B2 true JPH0138797B2 (US20100154141A1-20100624-C00001.png) | 1989-08-16 |
Family
ID=21815512
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP3479780A Granted JPS55129298A (en) | 1979-03-23 | 1980-03-21 | N*n**bis*2*33dihydroxypropyl**2*4*66triiodoo 55*22ketoollgulonamido*isophthalamide and irridiative composition containing it |
| JP1008741A Granted JPH02146A (ja) | 1979-03-23 | 1989-01-19 | ５‐アミノ‐ｎ，ｎ’―ビス（２，３‐ジ置換プロピル）‐２，４，６‐トリヨードイソフタルアミド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP1008741A Granted JPH02146A (ja) | 1979-03-23 | 1989-01-19 | ５‐アミノ‐ｎ，ｎ’―ビス（２，３‐ジ置換プロピル）‐２，４，６‐トリヨードイソフタルアミド |
Country Status (9)
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4314055A (en) * | 1975-09-29 | 1982-02-02 | Mallinckrodt, Inc. | 3,5-Disubstituted-2,4,6-triiodoanilides of polyhydroxy-monobasic acids |
| FR2435253A1 (fr) * | 1978-07-04 | 1980-04-04 | Nyegaard & Co As | Procede de preparation d'une solution tamponnee d'une substance de contraste pour rayons x, et produits obtenus par ce procede |
| AU3793293A (en) * | 1992-02-28 | 1993-09-13 | Mallinckrodt Medical, Inc. | Synthesis of ioversol using a minimal excess of acetoxyacetylchloride |
| GB9710726D0 (en) * | 1997-05-23 | 1997-07-16 | Nycomed Imaging As | Compound |
| GB9825095D0 (en) * | 1998-11-16 | 1999-01-13 | Nycomed Imaging As | Chemical process |
| AU2002245169A1 (en) | 2000-11-10 | 2002-07-08 | Wm. Marsh Rice University | Fullerene (c60)-based x-ray contrast agent for diagnostic imaging |
| JP2003098132A (ja) * | 2001-09-25 | 2003-04-03 | Sony Corp | 試料ホルダ及び試料分析装置 |
| EP2014708A1 (en) | 2005-01-13 | 2009-01-14 | Cinvention Ag | Shaped body made of a composite material |
| US20080213611A1 (en) * | 2007-01-19 | 2008-09-04 | Cinvention Ag | Porous, non-degradable implant made by powder molding |
| US20080213742A1 (en) * | 2007-02-28 | 2008-09-04 | Cinvention Ag | High surface cultivation system |
| CN101921209B (zh) * | 2010-09-09 | 2013-01-30 | 江苏省原子医学研究所 | 5-硝基-n,n′-双（2，3-二羟丙基）-1,3-苯二甲酰胺的制备方法 |
| KR101843337B1 (ko) | 2010-10-28 | 2018-03-30 | 삼성전자주식회사 | 디스플레이 모듈 및 디스플레이 시스템 |
| CN102399167A (zh) * | 2011-12-13 | 2012-04-04 | 江苏省原子医学研究所 | 一种5-氨基-n，n’-双(2，3-二羟丙基)-2，4，6-三碘异酞酰胺的制备方法 |
| CN109912445A (zh) * | 2019-02-26 | 2019-06-21 | 兄弟科技股份有限公司 | 碘海醇杂质f的合成方法及其在碘海醇杂质g、杂质h和杂质m合成中的应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3770820A (en) * | 1967-05-11 | 1973-11-06 | J Ackerman | Iodinated anilic acids |
| US4001323A (en) * | 1974-12-13 | 1977-01-04 | Savac Ag | Water-soluble, non-ionizing hydroxy-containing amide derivatives of 2,4,6-triiodo-isophthalic acid |
| JPS52130923A (en) * | 1976-04-27 | 1977-11-02 | Mallinckrodt Chemical Works | Xxray photographic agent |
| US4125599A (en) * | 1976-08-19 | 1978-11-14 | Mallinckrodt, Inc. | X-ray contrast agents |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL153083B (nl) * | 1969-06-27 | 1977-05-16 | Nijegaard & Co A S | Werkwijze ter bereiding van trijoodbenzoezuuramiden. |
| US3666760A (en) * | 1970-04-02 | 1972-05-30 | Sterling Drug Inc | Iodinated 3-aminobenzamides |
| SE7610681L (sv) * | 1975-09-29 | 1977-06-10 | Mallinckrodt Inc | Trijodanilider |
| GB1548594A (en) * | 1976-06-11 | 1979-07-18 | Nyegaard & Co As | Triiodoisophthalic acid amides |
| CH626873A5 (US20100154141A1-20100624-C00001.png) | 1977-03-28 | 1981-12-15 | Bracco Ind Chimica Spa |
-
1979
- 1979-03-23 US US06/023,509 patent/US4256729A/en not_active Expired - Lifetime
-
1980
- 1980-03-10 CA CA000347308A patent/CA1143725A/en not_active Expired
- 1980-03-11 GB GB8008227A patent/GB2046258B/en not_active Expired
- 1980-03-13 FR FR8005650A patent/FR2467216A1/fr active Granted
- 1980-03-17 DE DE3051154A patent/DE3051154C2/de not_active Expired - Fee Related
- 1980-03-17 DE DE19803010153 patent/DE3010153A1/de active Granted
- 1980-03-19 BE BE0/199855A patent/BE882309A/fr not_active IP Right Cessation
- 1980-03-20 AU AU56640/80A patent/AU538176B2/en not_active Ceased
- 1980-03-21 JP JP3479780A patent/JPS55129298A/ja active Granted
- 1980-03-21 NL NL8001672A patent/NL8001672A/xx not_active Application Discontinuation
-
1989
- 1989-01-19 JP JP1008741A patent/JPH02146A/ja active Granted
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3770820A (en) * | 1967-05-11 | 1973-11-06 | J Ackerman | Iodinated anilic acids |
| US4001323A (en) * | 1974-12-13 | 1977-01-04 | Savac Ag | Water-soluble, non-ionizing hydroxy-containing amide derivatives of 2,4,6-triiodo-isophthalic acid |
| JPS52130923A (en) * | 1976-04-27 | 1977-11-02 | Mallinckrodt Chemical Works | Xxray photographic agent |
| US4125599A (en) * | 1976-08-19 | 1978-11-14 | Mallinckrodt, Inc. | X-ray contrast agents |
Also Published As
| Publication number | Publication date |
|---|---|
| US4256729A (en) | 1981-03-17 |
| DE3010153A1 (de) | 1980-10-02 |
| JPH038333B2 (US20100154141A1-20100624-C00001.png) | 1991-02-05 |
| AU538176B2 (en) | 1984-08-02 |
| BE882309A (fr) | 1980-07-16 |
| GB2046258B (en) | 1983-04-20 |
| AU5664080A (en) | 1980-09-25 |
| DE3051154C2 (US20100154141A1-20100624-C00001.png) | 1992-09-17 |
| JPS55129298A (en) | 1980-10-06 |
| FR2467216A1 (fr) | 1981-04-17 |
| FR2467216B1 (US20100154141A1-20100624-C00001.png) | 1984-10-12 |
| GB2046258A (en) | 1980-11-12 |
| NL8001672A (nl) | 1980-09-25 |
| JPH02146A (ja) | 1990-01-05 |
| DE3010153C2 (US20100154141A1-20100624-C00001.png) | 1989-08-24 |
| CA1143725A (en) | 1983-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1198739A (en) | 2,4,6-triiodoisophthalamide derivative | |
| US4001323A (en) | Water-soluble, non-ionizing hydroxy-containing amide derivatives of 2,4,6-triiodo-isophthalic acid | |
| JPH0138797B2 (US20100154141A1-20100624-C00001.png) | ||
| JPS5827264B2 (ja) | ２，４，６−トリヨ−ド−イソフタ−ル酸の新規誘導体、その製造法及びこれを含有するレントゲン造影剤 | |
| EP0557345B1 (en) | 1,3-bis- 3-(mono- or poly-hydroxy)acylamino-5-(mono- or poly-hydroxyalkyl)aminocarbonyl-2,4,6-triiodo-benzoyl-amino]-hydroxy- or hydroxyalkyl-propanes, their methods of preparation and x-ray contrast media containing them | |
| US4547357A (en) | N-Hydroxyethylated 2,4,6-triiodoaminoisophthalic acid bistrihydroxybutylamides, their preparation and x-ray contrast media containing them | |
| CZ89597A3 (en) | Biphenyl compounds and a contrast agent containing thereof | |
| US5019371A (en) | Novel x-ray contrast agents, compositions and methods | |
| AU612510B2 (en) | Nonionic x-ray contrast agents, compositions and methods | |
| US4284620A (en) | N-(2-Hydroxyethyl)-2,4,6-triiodo-3,5-bis-(2-keto-L-gulonamido)benzamide and radiological compositions containing same | |
| SK35597A3 (en) | Iodinated x-ray-contrast media | |
| DE69214934T2 (de) | Nichtionische jodhaltige röntgenstrahlenkontrastmittel, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen | |
| US3647864A (en) | 5-substituted-1 3-benzenediacrylic and -dipropionic acids | |
| JP4190032B2 (ja) | アミノアルコールを精製する方法 | |
| WO1991009836A1 (fr) | Composes non ioniques iodes, leur procede de preparation et produits de contraste en contenant | |
| US5356613A (en) | X-ray contrast agents, compositions and methods | |
| US4175544A (en) | Iodo-aryl carbonates for use in methods in radiography | |
| JPH07502031A (ja) | ５，５’−／（１，３−プロパンジイル）ビスー／イミノ（２−オキソー２，１−エタンジイル）アセチルイミノ／ビス（２，４，６−トリヨードー１，３−ベンゼンジカルボキシアミド）類，およびこれらを含有する造影剤 | |
| DE19731591C2 (de) | Pharmazeutische Mittel enthaltend perfluoralkylgruppenhaltige Trijodaromaten und ihre Verwendung in der Tumortherapie und interventionellen Radiologie | |
| DE69401327T2 (de) | Nicht-ionische iod-dimere als röntgenkontrastmittel, verfahren zu ihrer herstellung und galenische zusammensetzungen die diese enthalten | |
| JPH08283189A (ja) | ビフェニルヨード化誘導体およびそれらの診断用途 | |
| CH334126A (fr) | Procédé de préparation de dérivés halogénés de l'acide benzoïque |